• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: MEDTRONIC IRELAND ENDURANT II BIFURCATED STENT GRAFT; SYSTEM, ENDOVASCULAR GRAFT, AORTIC ANEURYSM TREATMENT

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

MEDTRONIC IRELAND ENDURANT II BIFURCATED STENT GRAFT; SYSTEM, ENDOVASCULAR GRAFT, AORTIC ANEURYSM TREATMENT Back to Search Results
Model Number ETBF2813C145E
Medical Device Problem Code Occlusion Within Device (1423)
Health Effect - Clinical Code Occlusion (1984)
Date of Event 12/02/2017
Type of Reportable Event Serious Injury
Event or Problem Description
An endurant ii stent graft system was implanted in a patient for the endovascular treatment of an abdominal aortic aneurysm of unknown size.It was reported that the patient presented to the er with a cold leg.Ct performed revealed an occlusion of the patients right ipsilateral stent graft limb and reduced flow diameter in the contralateral left graft limb.Additionally, considerable thrombus build-up was noted in the aortic section of the bifurcated piece.On the same date, a thrombectomy was performed on the patient¿s contralateral limb to remove the clot and a stent was also placed in that area to improve flow on that side.A fem-fem bypass was performed to restore flow to the patients right lower extremity.It was noted that the patient has also been prescribed anti-coagulants to dissolve and retard clotting.The treatment performed resolved the issue.As per the physician, the cause of the event was due to hyper-coagulopathy and polycythemia of the patient.No additional clinical sequelae were reported, and the patient is fine.
 
Additional Manufacturer Narrative
Film review: the exact cause of the stent graft occlusion could not be determined from the limited films provided.Pre-implant anatomy was not provided, and images during implant were also not available.A single returned still angiogram from an unknown study date confirmed that the right/ipsi limb was 100% occluded beginning at the flow divider.In addition, there was substantial thrombus build-up along the inner wall of the bifurcate aortic body, as well as some thrombus seen within the contra limb especially near the distal end.Blood flow was observed only distal to the left limb.Analysis of the returned films did not reveal any stent graft characteristics that could explain the observed occlusion/thrombus.No obvious stent graft kinks or compression was observed with the devices.It is possible that this may have been caused by the reported patient condition; hyper-coagulopathy and polycythemia.Poor distal runoff may have also contributed.If information is provided in the future, a supplemental report will be issued.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
ENDURANT II BIFURCATED STENT GRAFT
Common Device Name
SYSTEM, ENDOVASCULAR GRAFT, AORTIC ANEURYSM TREATMENT
Manufacturer (Section D)
MEDTRONIC IRELAND
parkmore business park west
galway
MDR Report Key7132846
Report Number2953200-2017-02002
Device Sequence Number1310558
Product Code MIH
UDI-Device Identifier00613994991294
UDI-Public00613994991294
Combination Product (Y/N)N
Initial Reporter StateTN
Initial Reporter CountryUS
PMA/510(K) Number
P100021
Number of Events Summarized1
Summary Report (Y/N)N
Device Implanted Year2017
Reporter Type Manufacturer
Report Source company representative,health
Initial Reporter Occupation Physician
Type of Report Initial,Followup
Report Date (Section B) 01/17/2018
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Operator of Device Health Professional
Device Expiration Date09/13/2018
Device Model NumberETBF2813C145E
Device Catalogue NumberETBF2813C145E
Was Device Available for Evaluation? Device Returned to Manufacturer
Date Returned to Manufacturer12/05/2017
Initial Date Received by Manufacturer 12/03/2017
Supplement Date Received by Manufacturer12/22/2017
Initial Report FDA Received Date12/20/2017
Supplement Report FDA Received Date01/17/2018
Is This a Single-Use Device that was
Reprocessed and Reused on a Patient? (Y/N)
No
Patient Sequence Number1
Outcome Attributed to Adverse Event Required Intervention;
Patient Age60 YR
-
-